S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:NVCR

NovoCure News Headlines

$129.28
-3.97 (-2.98 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$117.49
Now: $129.28
$134.21
50-Day Range
$133.25
MA: $170.60
$190.17
52-Week Range
$53.40
Now: $129.28
$194.75
Volume1.21 million shs
Average Volume743,553 shs
Market Capitalization$13.24 billion
P/E Ratio680.46
Dividend YieldN/A
Beta1.29

Headlines

NovoCure (NASDAQ NVCR) News Headlines Today

Source:
SourceHeadline
Zacks Investment Research Downgrades NovoCure (NASDAQ:NVCR) to SellZacks Investment Research Downgrades NovoCure (NASDAQ:NVCR) to Sell
marketbeat.com - March 4 at 1:31 AM
iCAD (NASDAQ:ICAD) & NovoCure (NASDAQ:NVCR) Head to Head ContrastiCAD (NASDAQ:ICAD) & NovoCure (NASDAQ:NVCR) Head to Head Contrast
americanbankingnews.com - March 5 at 6:24 PM
NovoCure (NASDAQ:NVCR) Trading Down 8.5%NovoCure (NASDAQ:NVCR) Trading Down 8.5%
americanbankingnews.com - March 4 at 8:44 PM
Novocure Stock Likely To Slide Further After Delays In Clinical Studies? - NasdaqNovocure Stock Likely To Slide Further After Delays In Clinical Studies? - Nasdaq
nasdaq.com - March 3 at 7:40 PM
Mizuho Increases NovoCure (NASDAQ:NVCR) Price Target to $175.00Mizuho Increases NovoCure (NASDAQ:NVCR) Price Target to $175.00
americanbankingnews.com - March 1 at 7:59 AM
Edited Transcript of NVCR.OQ earnings conference call or presentation 25-Feb-21 1:00pm GMT - Yahoo FinanceEdited Transcript of NVCR.OQ earnings conference call or presentation 25-Feb-21 1:00pm GMT - Yahoo Finance
finance.yahoo.com - February 28 at 12:29 AM
Selling Before NVCR Stock Earnings Captured Quick GainSelling Before NVCR Stock Earnings Captured Quick Gain
finance.yahoo.com - February 26 at 7:29 PM
NovoCure Has Broken Down on the Charts: What to Do NowNovoCure Has Broken Down on the Charts: What to Do Now
finance.yahoo.com - February 26 at 9:29 AM
NovoCure (NVCR) Q4 2020 Earnings Call Transcript - Motley FoolNovoCure (NVCR) Q4 2020 Earnings Call Transcript - Motley Fool
fool.com - February 26 at 12:20 AM
NovoCure (NVCR) Q4 2020 Earnings Call TranscriptNovoCure (NVCR) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 26 at 12:20 AM
NovoCure (NASDAQ:NVCR) Stock Price Down 14%NovoCure (NASDAQ:NVCR) Stock Price Down 14%
americanbankingnews.com - February 25 at 10:20 PM
Novocure (NVCR) Misses Q4 EPS by 8c, Revenues Beat - StreetInsider.comNovocure (NVCR) Misses Q4 EPS by 8c, Revenues Beat - StreetInsider.com
streetinsider.com - February 25 at 2:20 PM
NovoCure EPS misses by $0.09, beats on revenue - Seeking AlphaNovoCure EPS misses by $0.09, beats on revenue - Seeking Alpha
seekingalpha.com - February 25 at 2:20 PM
Novocure Stock Plunges On Likelihood For Diminishing Sales Growth In 2021Novocure Stock Plunges On Likelihood For Diminishing Sales Growth In 2021
finance.yahoo.com - February 25 at 2:20 PM
NovoCure (NVCR) Q4 Earnings and Revenues Miss Estimates - NasdaqNovoCure (NVCR) Q4 Earnings and Revenues Miss Estimates - Nasdaq
nasdaq.com - February 25 at 8:44 AM
Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update - Business WireNovocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update - Business Wire
businesswire.com - February 25 at 8:44 AM
Sarepta, Vertex & Neurocrine: Out Of Favor Healthcare Stocks To Watch - NasdaqSarepta, Vertex & Neurocrine: Out Of Favor Healthcare Stocks To Watch - Nasdaq
nasdaq.com - February 25 at 1:15 AM
Why Earnings Season Could Be Great for NovoCure (NVCR) - NasdaqWhy Earnings Season Could Be Great for NovoCure (NVCR) - Nasdaq
nasdaq.com - February 24 at 10:13 AM
Interesting NVCR Put And Call Options For April 16th - NasdaqInteresting NVCR Put And Call Options For April 16th - Nasdaq
nasdaq.com - February 23 at 12:55 AM
NovoCure (NASDAQ:NVCR) Trading 8.2% Higher NovoCure (NASDAQ:NVCR) Trading 8.2% Higher
americanbankingnews.com - February 19 at 7:20 PM
NovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release - NasdaqNovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Nasdaq
nasdaq.com - February 18 at 7:52 PM
Validea Motley Fool Strategy Daily Upgrade Report - 2/17/2021 - NasdaqValidea Motley Fool Strategy Daily Upgrade Report - 2/17/2021 - Nasdaq
nasdaq.com - February 17 at 7:53 AM
Wells Fargo Growth Is One Of The Best Mutual Funds, But Does Not Own NetflixWells Fargo Growth Is One Of The Best Mutual Funds, But Does Not Own Netflix
finance.yahoo.com - February 13 at 8:33 AM
Evaluate Vantage 2020 Review: Biopharma IPOs and Venture Financing Break Records; Global Drug Stocks Add Half a Trillion Dollars in Market Capitalization - StreetInsider.comEvaluate Vantage 2020 Review: Biopharma IPOs and Venture Financing Break Records; Global Drug Stocks Add Half a Trillion Dollars in Market Capitalization - StreetInsider.com
streetinsider.com - February 11 at 7:46 AM
Noteworthy Monday Option Activity: RCL, PLAY, NVCR - NasdaqNoteworthy Monday Option Activity: RCL, PLAY, NVCR - Nasdaq
nasdaq.com - February 9 at 12:09 AM
Novocure Announces Addition to Its Board of DirectorsNovocure Announces Addition to Its Board of Directors
finance.yahoo.com - February 8 at 7:08 PM
Novocure Finds SupportNovocure Finds Support
finance.yahoo.com - January 28 at 6:03 PM
IBD Stock Of The Day Presents Investors With A Tricky Choice — Buy Or SellIBD Stock Of The Day Presents Investors With A Tricky Choice — Buy Or Sell
finance.yahoo.com - January 28 at 6:03 PM
When Should You Buy NovoCure Limited (NASDAQ:NVCR)?When Should You Buy NovoCure Limited (NASDAQ:NVCR)?
finance.yahoo.com - January 28 at 1:03 PM
1 Overlooked Reason Why You May Regret Cosigning a Loan - Nasdaq1 Overlooked Reason Why You May Regret Cosigning a Loan - Nasdaq
nasdaq.com - January 24 at 10:39 PM
How to Calculate a Tax Holding Period for Stock Investments - NasdaqHow to Calculate a Tax Holding Period for Stock Investments - Nasdaq
nasdaq.com - January 24 at 12:38 PM
Investors Take Note: This Biotech Stock Has Multiple Readouts in 2021 - Motley FoolInvestors Take Note: This Biotech Stock Has Multiple Readouts in 2021 - Motley Fool
fool.com - January 24 at 12:38 PM
Investors Take Note: This Biotech Stock Has Multiple Readouts in 2021Investors Take Note: This Biotech Stock Has Multiple Readouts in 2021
finance.yahoo.com - January 24 at 12:38 PM
Novocure Ltd.: A Shockingly Good Potential Ten Bagger - Seeking AlphaNovocure Ltd.: A Shockingly Good Potential Ten Bagger - Seeking Alpha
seekingalpha.com - January 21 at 12:31 PM
Neurocrine, Ionis, Vertex: Underperforming Healthcare Stocks Poised To Recover - ForbesNeurocrine, Ionis, Vertex: Underperforming Healthcare Stocks Poised To Recover - Forbes
forbes.com - January 19 at 3:15 PM
First Week of NVCR September 17th Options Trading - NasdaqFirst Week of NVCR September 17th Options Trading - Nasdaq
nasdaq.com - January 19 at 3:15 PM
Are Options Traders Betting on a Big Move in NovoCure (NVCR) Stock? - Yahoo FinanceAre Options Traders Betting on a Big Move in NovoCure (NVCR) Stock? - Yahoo Finance
finance.yahoo.com - January 16 at 9:00 AM
Are Options Traders Betting on a Big Move in NovoCure (NVCR) Stock? - NasdaqAre Options Traders Betting on a Big Move in NovoCure (NVCR) Stock? - Nasdaq
nasdaq.com - January 15 at 9:48 AM
Are Options Traders Betting on a Big Move in NovoCure (NVCR) Stock?Are Options Traders Betting on a Big Move in NovoCure (NVCR) Stock?
finance.yahoo.com - January 15 at 9:48 AM
Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update - Yahoo FinanceNovocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update - Yahoo Finance
finance.yahoo.com - January 13 at 8:38 AM
Alpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member - PRNewswireAlpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member - PRNewswire
prnewswire.com - January 12 at 1:44 PM
Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update - Business WireNovocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update - Business Wire
businesswire.com - January 12 at 8:44 AM
NovoCure guides Q4 revenues above estimates - Seeking AlphaNovoCure guides Q4 revenues above estimates - Seeking Alpha
seekingalpha.com - January 11 at 7:39 AM
Discovery Rolls Out Streaming Service On Amazon Fire TV And Roku – Report - NasdaqDiscovery Rolls Out Streaming Service On Amazon Fire TV And Roku – Report - Nasdaq
nasdaq.com - January 4 at 7:16 PM
NovoCure Could Weaken Further in the Days AheadNovoCure Could Weaken Further in the Days Ahead
finance.yahoo.com - January 4 at 2:16 PM
BioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021? - ForbesBioMarin, Alkermes, Ionis: Are These Health Care Stocks Set To Outperform In 2021? - Forbes
forbes.com - January 4 at 9:10 AM
Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference - Yahoo FinanceNovocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference - Yahoo Finance
finance.yahoo.com - December 25 at 11:10 PM
Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare ConferenceNovocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference
finance.yahoo.com - December 23 at 8:18 AM
Novocure (NVCR) CEO Asaf Danziger Sold $32.7 million of Shares - Yahoo FinanceNovocure (NVCR) CEO Asaf Danziger Sold $32.7 million of Shares - Yahoo Finance
finance.yahoo.com - December 23 at 12:17 AM
Why Novocure, Leading Medical Devices Stock, Is One To Watch In 2021 - Yahoo FinanceWhy Novocure, Leading Medical Devices Stock, Is One To Watch In 2021 - Yahoo Finance
finance.yahoo.com - December 21 at 10:32 PM
Is NVCR A Good Stock To Buy Now According To Hedge Funds? - Yahoo FinanceIs NVCR A Good Stock To Buy Now According To Hedge Funds? - Yahoo Finance
finance.yahoo.com - December 20 at 3:01 PM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.